Varda Shoshan-Barmaz

30PUBLICATIONS
34CO-AUTHORS
Medical virologyMolecular targetsGene and molecular therapyQuality assurance, chemometrics, traceability and metrological chemistryPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|May 04, 2026
MAVS as a Key Regulator of Tumor Proliferation, Survival, the Tumor Microenvironment, and Immunity.

|Apr 23, 2026
Disrupting VDAC1-tubulin interaction uncovers crosstalk between mitochondrial and microtubule functions with implication to cancer therapy.

|Jan 28, 2026
p53 Interacts with VDAC1, Modulating Its Expression Level and Oligomeric State to Activate Apoptosis.

Elinor Gigi, Aditya Karunanithi Nivedita, Danya Ben-Hail

|May 14, 2025
Resveratrol's Pro-Apoptotic Effects in Cancer Are Mediated Through the Interaction and Oligomerization of the Mitochondrial VDAC1.

Tal Raviv, Anna Shteinfer-Kuzmine, Meital M Moyal

|May 10, 2025
Correction to: Elevated serum mtDNA in COVID‑19 patients is linked to SARS‑CoV‑2 envelope protein targeting mitochondrial VDAC1, inducing apoptosis and mtDNA release.

Anna Shteinfer-Kuzmine, Ankit Verma, Rut Bornshten

|May 09, 2025
Annexin A5 controls VDAC1-dependent mitochondrial Ca2+ homeostasis and determines cellular susceptibility to apoptosis.

Furkan E Oflaz, Alexander I Bondarenko, Michael Trenker

Pageof 5

Frequent Collaborators

6 joint publications

Anna Shteinfer-Kuzmine

5 joint publications

Tasleem Arif

4 joint publications

Swaroop Kumar Pandey

2 joint publications

Aditya Karunanithi Nivedita